Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation

BACKGROUND: The use of liver transplantation (LT) in patients with stage IV neuroendocrine pancreatic tumors (pan-NET) is under debate. Previous studies report a 5-year survival of 27–53% after LT in pan-NET and up to 92.7% in patients with mixed NETs. This study aimed to determine survival rates of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjaer, Josefine, Smith, Sara, Hellman, Per, Stålberg, Peter, Crona, Joakim, Welin, Staffan, Norlén, Olov
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Scientific Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803729/
https://www.ncbi.nlm.nih.gov/pubmed/36175647
http://dx.doi.org/10.1007/s00268-022-06736-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803729/
https://www.ncbi.nlm.nih.gov/pubmed/36175647
http://dx.doi.org/10.1007/s00268-022-06736-1

Ejemplares similares